Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies

NCT03353753 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: DCC-2618
DRUG: Placebo Oral Tablet

Sponsor

Deciphera Pharmaceuticals, LLC